Is URGN a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Urogen Pharma Ltd (URGN) is (104.69) USD. With the latest stock price at 11.66 USD, the upside of Urogen Pharma Ltd based on DCF is -997.9%. This means that URGN is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.4% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (231.45) - (68.76) | (104.69) |
| Upside | -2085.0% - -689.8% | -997.9% |